Page last updated: 2024-10-31

deoxyepinephrine and Interstitial Nephritis

deoxyepinephrine has been researched along with Interstitial Nephritis in 2 studies

Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.

Research Excerpts

ExcerptRelevanceReference
"Ibopamine treatment was ineffective in Group 2, while in Group 1 patients there was a statistically significant increase in creatinine clearance (+23% after 3 months, +31% after 6 months)."2.65Long-term treatment of chronic renal insufficiency with Ibopamine (SB 7505), a new orally active dopamine-related drug. ( Colí, L; Docci, D; Mosconi, G; Prandini, R; Stefoni, S; Vangelista, A, 1982)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stefoni, S1
Docci, D2
Vangelista, A1
Mosconi, G1
Colí, L1
Prandini, R1
Pistocchi, E1
Turci, F1
Baldrati, L1

Trials

1 trial available for deoxyepinephrine and Interstitial Nephritis

ArticleYear
Long-term treatment of chronic renal insufficiency with Ibopamine (SB 7505), a new orally active dopamine-related drug.
    Clinical nephrology, 1982, Volume: 18, Issue:4

    Topics: Administration, Oral; Adult; Aged; Chronic Disease; Clinical Trials as Topic; Creatinine; Deoxyepine

1982

Other Studies

1 other study available for deoxyepinephrine and Interstitial Nephritis

ArticleYear
Effect of ibopamine on the progression of chronic renal failure.
    Clinical nephrology, 1986, Volume: 26, Issue:3

    Topics: Adult; Creatinine; Deoxyepinephrine; Diuretics; Dopamine; Female; Glomerulonephritis; Humans; Kidney

1986